Drawing for SPINCHIP

USPTO serial 97590351

SPINCHIP

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ROTH, BENJAMIN H.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with SPINCHIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $449*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Martin M. Zoltick

Martin M. Zoltick Rothwell, Figg, Ernst & Manbeck, PC901 New York Avenue, NWSuite 900 EastWashington, DC 20001

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters for medical purposes; materials for dressings in the nature of wadding for dressing, gauze for dressing; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; diagnostic reagents for medical purposes; diagnostic substances for medical use; diagnostic preparations and substances for medical purposes; in vitro diagnostic preparations for medical use; diagnostic test materials for medical use, namely, medical diagnostic test strips and assay cartridges for blood analysis, urine analysis, saliva analysis, medical diagnostic reagents and assays for testing of bodily fluids; chemical preparations for pharmaceutical or medical purposes, namely, for testing of blood for medical purposes; reagents for analytical purposes in the nature of diagnostic reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; disposable and reusable test capsules and test materials, indicators and diagnostic preparations in the nature of diagnostic agents, preparations and substances for medical and veterinary purposes for in vitro diagnostic testing of samples taken from humans and animalsACTIVE—
009Scientific, surveying, photographic, cinematographic, optical, weighing, measuring, signaling, checking, supervising, life-saving and teaching apparatus and instruments, namely, medical diagnostic simulators for use as teaching aids for testing sample collection equipment in the nature of optical apparatus, test apparatus and test instruments for bodily fluids for use in medical diagnostics, consisting of wipes, swabs and assay cartridges for use in diagnostic testing, all not for actual medical purposes; data processing equipment, including computer components for use in medical diagnostics, computers, including computers for use in medical diagnostics; Downloadable and recorded computer software for conducting, controlling and reading of test apparatus for fluidsACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, apparatus and instruments for in- vitro diagnostic testing, namely, medical diagnostic apparatus for testing blood sugar levels, cancer cells, DNA, body fluids, proteins, antigens, virus, bacteria, fungi, drugs, metabolites, lipids, ions in blood samples, tissue fluids, urine samples, tissue samples and mucous samples and for detecting drugs including ethanol, methanol, opiates, cocaine and amphetamine in blood, urine or saliva samples; optical medical apparatus and instruments for in-vitro diagnostic testing and analysis of blood sugar levels, cancer cells, DNA, body fluids, proteins, antigens, virus, bacteria, fungi, drugs, metabolites, lipids, ions in blood samples, tissue fluids, urine samples, tissue samples and mucous samples and for detecting drugs including ethanol, methanol, opiates, cocaine and amphetamine in blood, urine or saliva samples; artificial limbs, eyes and teeth; suture materialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2026EX5GSOU EXTENSION 5 GRANTED—
Aug 11, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 15, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2026EXT5SOU EXTENSION 5 FILED—
Apr 8, 2026ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 20, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 19, 2025EX4GSOU EXTENSION 4 GRANTED—
Dec 19, 2025EXT4SOU EXTENSION 4 FILED—
Dec 19, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 18, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 18, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 18, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 18, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 15, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2025EX3GSOU EXTENSION 3 GRANTED—
Jun 4, 2025EXT3SOU EXTENSION 3 FILED—
Jun 4, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 2, 2025EX2GSOU EXTENSION 2 GRANTED—
Jan 2, 2025EXT2SOU EXTENSION 2 FILED—
Jan 2, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 31, 2024EX1GSOU EXTENSION 1 GRANTED—
May 31, 2024EXT1SOU EXTENSION 1 FILED—
May 31, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 7, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 7, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 29, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 7, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 7, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 26, 2023DOCKASSIGNED TO EXAMINER—
Sep 29, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance